Pfizer Sends First Data to FDA on COVID Vaccines for Younger Kids
TUESDAY, Sept. 28, 2021 (HealthDay News) — Pfizer Inc. announced Tuesday that it has submitted initial data to federal regulators on the efficacy of its COVID-19 vaccine among younger children. The company is also expected to submit the same data on kids aged 5 to 11 to the European MedicinesContinue Reading